Related Articles
Molecular and immunological aspects of p53 and p53-autoantibodies in head and neck squamous cell carcinoma
WAF1 expression is independent of p53 gene alterations and protein expression in human lung cancer cells
Mutant p53 protein in serum could be used as a molecular marker in human breast cancer
p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer.
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma